Despite a number of metabolic perturbations found in cancer cells, IDH mutations are unique as driver mutations, acting as proto-oncogenes for tumor maintenance [37] and similarly producing a cell state permissive of transformation by alterations to the cell methylome [43]. The gene discussed is IDH2; the disease is cancer.